As of 2024-12-15, the Fair Value of NGM Biopharmaceuticals Inc (NGM) is -8.53 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.54 USD, the upside of NGM Biopharmaceuticals Inc is -653.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -42.80 | -102.50 | -120.30 | -162.70 | -142.37 | -114.13 |
| YoY growth | -8,460.00% | -139.49% | -17.37% | -35.25% | 12.49% | -1,727.92% |
| Market Cap (mil) | 128.53 |
| P/E | |
| Forward P/E | -0.90x |
| EPS | -1.71 |
| Avg earnings growth rate | -1,727.92% |
| TTM earnings | -142.38 |